Andrew Levin, MD, PhD

Advisor

Andrew Levin is an Advisor with the Investment team at RA Capital Management. He previously served as Partner and Managing Director of RA Capital. Prior to RA Capital, Andrew served as a Vice President at H.I.G. BioVentures and Director of Pharmaceutical Sciences at the Clinton Health Access Initiative. Andrew holds a Bachelor of Science in Engineering in Mechanical Engineering from Princeton University, a PhD in Biomedical Engineering from the Massachusetts Institute of Technology, and an MD from Harvard Medical School.